Episode 126: AML Series, Pt 12 - Treatment of patients with relapsed/refractory disease
The Fellow on Call: The Heme/Onc Podcast
Navigating Treatment Options in Relapsed/Refractory Disease
This chapter explores the intricate decision-making process involved in selecting treatment regimens for patients with relapsed or refractory diseases. Emphasizing individual patient considerations and the impact of clinical trials, the speakers convey a hopeful perspective on the advancements in therapeutic options.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
